Novoprotein Scientific Inc. (SHA:688137)
China flag China · Delayed Price · Currency is CNY
32.27
+0.06 (0.19%)
At close: Apr 18, 2025, 2:57 PM CST

Novoprotein Scientific Company Description

Novoprotein Scientific Inc. researches, develops, produces, and sells raw materials and technical solutions for bio-pharmaceutical enterprises and research institutions in Asia, Europe, the United States, and Oceania.

It offers cytokines, target proteins, mRNA vaccine and drug enzymes, recombinant antibodies, and molecular enzymes and reagents; and gene and cell therapy, molecular research and diagnosis, and SRAS-CoV-2 and SARS-CoV-2 related products, as well as related technical services.

The company also provides protein expression and purification, antibody, industrial strain and process development, stable cell line, VLP protein, protein crystallization, protein modification and labeling, MHC I-peptide complex protein preparation, antibody development, mRNA synthesis custom, and vaccine development services.

It offers its products and services in the fields of biopharmaceuticals, mRNA vaccines and drugs, in vitro diagnostics, biological drugs, basic research of life sciences, and other areas.

The company was founded in 2009 and is headquartered in Suzhou, China.

Novoprotein Scientific Inc.
Country China
Founded 2009
Industry Biotechnology
Sector Healthcare
Employees 579
CEO Huaxing Zhu

Contact Details

Address:
No.228, Yunchuang Road
Suzhou, 215299
China
Phone 86 512 6391 9116
Website novoprotein.com.cn

Stock Details

Ticker Symbol 688137
Exchange Shanghai Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
SIC Code 2836

Key Executives

Name Position
Dr. Huaxing Zhu Founder, Chairman and GM
Dongye Zhang Accounting Supervisor and Chief Financial Officer
Yingming Wang Deputy GM and Director
Yujian Zhao Deputy GM and Director
Duqiang Wang Deputy GM, Secretary and Director